Search

everythinglearnresearchcommunity

for

Search:↓

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

PRF lysates reduce inflammation in cancer cells and boost immune response in healthy oral cells.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Leucocyte-rich platelet-rich plasma boosts cell activity and helps wound healing.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Platelet Rich Plasma reduces psoriasis symptoms but isn't enough alone for treatment.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Blocking IL-8 can reduce skin rashes from cancer treatment.

El plasma rico en plaquetas puede ayudar en la regeneración celular y podría ser útil en tratamientos complementarios para enfermedades sin cura específica.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Platelet-rich plasma therapy helps heal skin ulcers and stimulates hair growth in dermatology.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Transplanting small skin grafts can successfully repigment leukoderma.

LEKTI is crucial for skin barrier and immune function, affecting conditions like Netherton syndrome and atopic dermatitis.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

EK significantly improved wound healing and reduced infection in burn wounds.

Fresh plasma transfusions did not help treat Leiner disease in an infant.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Biomimetic nanovesicles can speed up diabetic wound healing by regulating immune cell behavior and metabolism.

Platelet-rich plasma treatments reduce knee osteoarthritis inflammation, with pure PRP being more effective.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.